What happened to CSL’s price movement after its last earnings report? Which hedge fund is a major shareholder of CSL? --- Company Description CSL CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It ...
CSL Ltd + Add to watchlist CSJ:BRN Actions Price (CHF)180.92 Today's Change0.00 / 0.00% Shares traded230.00 1 Year change-- Beta-- Data delayed at least 15 minutes, as of Jul 18 2024. Find More Stocks Use our equities screener to discover other potential opportunities. Find Stocks ...
Shares of the Australia-based CSL Ltd. (AU:CSL) fell by over 4% as of writing despite the company achieving higher profit in FY24. The company reported an NPAT (net profit after tax) attributable to shareholders of $2.75 billion for the year, marking a 2
The article reports that CSL Ltd. received varying rating despite positive news. It states that the Royal Bank of Scotland (RBS) upgraded it to buy and cites a decision of the U.S. Federal Drugs Administration's advisory committee that recommends CSL vaccines Gardasil and Cervarix. Moreover, ...
Latest CSL Finance Ltd (CSLFINANCE:NSI) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
CSL Ltd CSLStock XASX Rating as of Nov 4, 2024Read Company Report Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Financial Statements Income Statement Balance Sheet Cash Flow Annual As ...
5-Nov-2024 Change of Director's Interest Notice 5-Nov-2024 Notification regarding unquoted securities - CSL View All Investor Announcements SHARE PRICE $287.32 CSL Mkt Cap: $139B The Market is currently CLOSED Price Delay ~20min Jun Jul Aug Sep Oct Nov $270 $280 $290 $300 $310 $320 ...
CSL Limited and Vifor Pharma Ltd, a global specialty pharmaceutical company with an emphasis in iron deficiency, nephrology & cardio-renal therapies have entered into a definitive agreement for CSL to acquire Vifor Pharma for an aggregate equity value for Vifor Pharma of US$ 11.7...
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on theearnings callit's worth handicapping the probability of a positive EPS surprise.
We’ll never share your email address with a third-party. Customer Services About Us Privacy Policy Buy on Corr Face Sell on Corr Face Trade Services CORRFACE CONSULTING&SERVICE CO.,LTD Room 1001, Building 5, Xizi International Center, No.898 Xiuwen Road,Minhang District,Shanghai,Chin...